(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

FIBROMYALGIA RELIEF

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

FIBROMYALGIA RELIEF

ST13

US500000077382313

Class

5

Filing

77382313

Registration

3730187

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

02/10/2020

Trademark type

Word

Nice classes

5

Filing date

01/28/2008

Registration date

12/22/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/10/2020

Last transaction

02/10/2020

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

10/16/2009

First use in commerce

10/16/2009

Drawing code

4

Owner type

03

Owner location

Reno, NV, US

Examiner

STRUCK, ROBERT J

Law office

L90

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

T.R.P. Company, Inc.

Representatives

John D. Long, Esq. LONG & CHYBIK

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

homeopathic pharmaceutical used to treat Fibromyalgia and symptoms of Fibromyalgia

Publications

History of USPTO decisions and trademark events.

41 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

02/10/2020

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/10/2020

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/10/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/06/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/23/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

12/23/2019

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/22/2018

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

01/23/2016

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

01/23/2016

PLGL

ASSIGNED TO PARALEGAL

01/23/2016

XXXX

POST REGISTRATION ACTION CORRECTION

01/23/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/23/2016

ES8R

TEAS SECTION 8 RECEIVED

12/28/2015

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

12/22/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/13/2009

ALIE

ASSIGNED TO LIE

11/13/2009

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

10/29/2009

IUAA

USE AMENDMENT ACCEPTED

10/29/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/21/2009

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

10/21/2009

IUAF

USE AMENDMENT FILED

10/21/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/20/2009

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/20/2009

EAAU

TEAS AMENDMENT OF USE RECEIVED

10/20/2009

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/20/2009

GNFR

FINAL REFUSAL E-MAILED

04/20/2009

CNFR

FINAL REFUSAL WRITTEN

04/20/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/28/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/27/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/27/2009

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/29/2008

GNRT

NON-FINAL ACTION E-MAILED

09/29/2008

CNRT

NON-FINAL ACTION WRITTEN

09/29/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/10/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/10/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/10/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/10/2008

GNRT

NON-FINAL ACTION E-MAILED

03/10/2008

CNRT

NON-FINAL ACTION WRITTEN

03/10/2008

DOCK

ASSIGNED TO EXAMINER

03/07/2008

NWAP

NEW APPLICATION ENTERED

01/31/2008

Continuous trademark protection

Get notified about every new filing that threatens FIBROMYALGIA RELIEF or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.